In an exceptional move, France’s High Authority for Health (HAS) has paved the way for the national health system to reimburse a video game designed for children. The digital therapeutic, named Poppins, targets dyslexia in children aged 7 to 11 and has received a preliminary green light, though final validation of its effectiveness is still required.
A Landmark Decision for Digital Therapy
The HAS published a “favorable opinion for early coverage” of the application on Tuesday, June 30, 2026. This critical step opens the door for the app to be covered by the French Social Security system, contingent on a final decision by the Ministry of Health and a pricing agreement. The decision marks only the second time the HAS has approved a mobile health application for reimbursement, following the green light given in April to Ludocare, an app assisting children with asthma.
Poppins distinguishes itself by presenting as a clear-cut video game. It offers daily 20-minute activities designed to improve how a dyslexic child processes words and syllables. The HAS, however, stressed that the application is intended as a supplement to, not a replacement for, traditional speech therapy.
Conditional Approval and Pending Data
The “early” coverage status indicates that while the device is considered innovative enough to warrant immediate support, the data on its efficacy must still be confirmed and enriched. The HAS’s decision was primarily based on a study involving approximately 300 children, which showed better reading performance in the group that used the application.
Nevertheless, other studies presented by Poppins were less conclusive. Consequently, the health authority has mandated that the company provide new data within six months. This follow-up is specifically required to determine if the device genuinely helps children improve their language comprehension.
The move highlights the booming market for digital medical tools, even as questions about their value and reimbursement persist. In contrast to France, Germany already reimburses nearly fifty such digital health applications, though it employs different evaluation methods.
